Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$270,105,594
+$44,111,735 QoQ
Shares Held
1,073,381
+3.3% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#127
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $1,455,266,466 across 11 Drug Manufacturers - General names. ABBV ranks #3 (18.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
2,829,082 | $357,426,219 | |
| 2 | JNJ |
Johnson & Johnson
|
1,198,505 | $304,384,314 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,073,381 | $270,105,594 | |
| 4 | AMGN |
Amgen Inc
|
697,030 | $252,408,503 | |
| 5 | LLY |
ELI LILLY & Co
|
129,204 | $154,971,166 | |
| 6 | MRK |
Merck & Co., Inc.
|
517,507 | $66,499,649 | |
| 7 | PFE |
Pfizer Inc
|
906,089 | $21,818,623 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
335,197 | $19,314,051 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $270,105,594 | 1,073,381 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $225,993,859 | 1,039,100 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $236,024,229 | 1,032,974 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $275,436,510 | 1,189,585 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $225,523,102 | 1,214,972 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $268,708,142 | 1,282,494 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $224,345,006 | 1,262,493 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $247,329,678 | 1,252,429 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $224,636,999 | 1,309,684 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $233,742,831 | 1,283,596 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $206,796,617 | 1,334,430 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $229,207,624 | 1,537,687 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $181,219,260 | 1,345,055 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $230,041,032 | 1,443,440 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $215,771,328 | 1,335,136 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $177,889,852 | 1,325,459 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $207,153,801 | 1,352,532 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $252,889,816 | 1,559,989 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $237,156,755 | 1,751,527 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $163,257,469 | 1,513,465 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $168,982,415 | 1,500,199 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $138,451,473 | 1,279,352 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $156,616,654 | 1,461,658 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $104,349,470 | 1,191,340 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $115,701,006 | 1,178,458 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $106,301,735 | 1,395,219 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||